Cisplatin Clinical Trials in Nijmegen
2 recruitingNijmegen, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca150 enrolled59 locationsNCT06960577
Recruiting
Phase 3
Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute100 enrolled5 locationsNCT07281508